Proapoptotic potentials of genistein under growth stimulation by estrogen

Annals of the New York Academy of Sciences

Volumn 1030, Issue , 2004, Pages 410-418

  Park, Ock Jin ^a   Shin, Jang In ^a  

^a Hannam University   (South Korea)

Author keywords

Apoptosis; Apoptosis related protein expression; Estrogen; Genistein; MCF 7 cells

Indexed keywords

CYCLIN B1; DNA FRAGMENT; ESTRADIOL; GENISTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DNA DETERMINATION; DOWN REGULATION; FEMALE; GROWTH STIMULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING;

MINK CELL FOCUS-FORMING VIRUS;

EID: 15044356397     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1329.051     Document Type: Conference Paper

References (35)

1. BRZOZOWSKI, A.M., C.W. PIKE, Z. DAUTER, et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758.
2. ZAVA, D.T. & G. DUWE. 1997. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 27: 31-40.
3. HSIEH, C.Y., R.C. SANTELL, S.Z. HASLAM, et al. 1998. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58: 3833-3838.
4. PETERSON, G. & S. BARNES. 1996. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 7: 1345-1351.
5. PAGLIACCI, M.C., M. SMACCHIA, G. MIGLIORATI, et al. 1994. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer 11: 1675-1682.
6. COLDITZ, G.A. 1998. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst. 90: 814-823.
7. SHUTT, D.A. & R.I. Cox. 1972. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J. Endocrinol. 52: 299-310.
8. MARTIN, P.M., K.B. HORWITZ, D.S. RYAN, et al. 1978. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103: 1860-1867.
9. PETERSON, G. & S. BARNES. 1991. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 19: 661-667.
10. 2/M arrest, and apoptosis. J. Cell. Biochem. 69: 44-54.
11. SHAO, Z.M., Z.Z. SHEN, J.A. FONTANA, et al. 2000. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res. 20: 2409-2416.
12. TWADDLE, G.M., J. TURBOV, N. LIU, et al. 1999. Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro. J. Surg. Oncol. 70: 83-90.
13. SHAO, Z.M.J., Z.Z. WU & S.H. BARSKY. 1998. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58: 4851-4857.
14. ALLRED, C.D., K.F. ALLRED, S.M. VIRANT, et al. 2001. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 61: 5045-5050.
15. TRAGANOS, F., B. ARDELT, N. HALKO, et al. 1992. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52: 6200-6208.
16. MATSUKAWA, Y., N. MARUI, T. SAKAE, et al. 1993. Genistein arrests cell cycle progression at G2-M. Cancer Res. 53: 1328-1331.
17. LI, Y., S. UPADHYAY, M. BHUIYAN, et al. 1999. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18: 3166-3172.
18. LIAN, F., Y. LI, M. BHUIYAN, et al. 1999. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr. Cancer 33: 125-131.
19. CONSTATINOU, A.I., N. KAMATH & J.S. MURLEY. 1998. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer 34: 1927-1934.
20. LEUNG, L.K., & T.T. WANG. 2000. Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration. J. Nutr. 130: 2922-2926.
21. XU, J. & G. LOO. 2001. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J. Cell. Biochem. 82: 78-88.
22. ZOUBINE, M.N., A.P. WESTON, D.C. JOHNSON, et al. 1999. 2-Methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Int. J. Oncol. 4: 639-646.
23. THOMAS, T. & T.J.THOMAS. 1994. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res. 54: 1077-1084.
24. BALABHADRAPATHRUNI, S., T.J. THOMAS, E.J. YURKOW, et al. 2000. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol. Rep. 7: 3-12.
25. CHOI, Y.H., W.H. LEE, K.Y. PARK, et al. 2000. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91: 164-173.
26. PARK, J.H., E.J. OH, Y.H. CHOI, et al. 2001. Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells. Int. J. Oncol. 18: 997-1002.
27. YE, R., A. BODERO, B. ZHOUS, et al. 2001. The plant isoflavonoid genistein activates p53 and Chk2 in an ATM-dependent manner. J. Biol. Chem. 276: 4828-4833.
28. NENCI, I., E. MARCHETTI & P. QUERZOLI. 1988. Commentary on human mammary preneoplasia. The estrogen receptor-promotion hypothesis. J. Steroid Biochem. 30: 105-106.
29. PERILLO, B., A. SASSO, C. ABBONDANZA, et al. 2000. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 20: 2890-2901.
30. MINN, A.J., R.E. SWAIN, A. MA, et al. 1998. Recent progress on the regulation of apoptosis by bcl-2 family members. Adv. Immunol. 70: 245-279.
31. WAF1. Clin. Cancer Res. 7: 1782-1789.
32. LAI, A., B. SARCEVIC, O.W. PRALL, et al. 2001. Insulin/IGF-1 and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21WAF1/Cip1. J. Biol. Chem. 276: 25823-25833.
33. PRALL, O.W., J.S. CARROLL & R.L. SUTHERLAND. 2001. A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E-Cdk2. J. Biol. Chem. 48: 45433-45442.
34. TSHILIAS, J., L. KAPUSTA & J. SLINGERLAND. 1999. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50: 401-423.
35. BEEKEN, S.W., W.E. GRIZZLE, D.R. CROWE, et al. 2001. Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53. Ann. Surg. 5: 630-638.